$0.00
(+0.00%
) Quote details
USD
+$0.00
(+0.00%
)At Close (As of Dec 12, 2025)
$55.72M
Market Cap
-
P/E Ratio
-1.62
EPS
$2.99
52 Week High
$0.87
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Adlai Nortye Ltd. is a clinical-stage biotechnology company focused on the research and development of innovative cancer therapies, primarily targeting opportunities in the United States and Mainland China. Headquartered in Grand Cayman, the firm is committed to leveraging cutting-edge scientific methodologies to meet significant unmet medical needs in oncology. With a strong and diverse pipeline, Adlai Nortye is strategically positioned to make a meaningful impact in the cancer treatment landscape, paving the way for potential collaborations and partnerships within the biopharmaceutical industry.
LPTX
NVDA
CGC
WOK
PLUG
KIND
TSLA
TLRY
KAVL
AVGO
TNYA
ADAP
ASST
INTC
APLT
SOFI
PLTD
WULF
DNN
PLTR
IRBT
MTSR
RR
ASBP
MARA
FI
NFLX
F
VALE
AAL
RKLB
IVP
BITF
CLSK
AMD
GOOGL
HOOD
SNAP
CAN
CIFR
GRAB
SOUN
NIO
WBD
QBTS
PFE
HL
RIG
AG
IBRX
MU
BAC
CDE
BYND
RGTI
SHOT
LULU
APLD
ZAPP
BTBT
BLNK
T
PCG
ORCL
LPTX
NVDA
CGC
WOK
PLUG
KIND
TSLA
TLRY
KAVL
AVGO
TNYA
ADAP
ASST
INTC
APLT
SOFI
PLTD
WULF
DNN
PLTR
IRBT
MTSR
RR
ASBP
MARA
FI
NFLX
F
VALE
AAL
RKLB
IVP
BITF
CLSK
AMD
GOOGL
HOOD
SNAP
CAN
CIFR
GRAB
SOUN
NIO
WBD
QBTS
PFE
HL
RIG
AG
IBRX
MU
BAC
CDE
BYND
RGTI
SHOT
LULU
APLD
ZAPP
BTBT
BLNK
T
PCG
ORCL